Month: March 2023

Fact: women’s sports receive less recognition and pay than their men counterparts. Some might say men’s sports have higher-quality coverage and commentary, larger production values, and more fans. As a lover of the game, it’s frustrating to see fewer camera angles and instant replays during women’s basketball games in comparison to men’s — no wonder
0 Comments
Welcome to our March research update! Getting involved with research is an important way to impact asthma and allergy treatments, education, and awareness. The Asthma and Allergy Foundation of America (AAFA) works with doctors, researchers, patients, caregivers, public health, and government agencies to conduct and support research that is important to people affected by asthma
0 Comments
In a recent study published in Nature, researchers assessed the impact of urban living on the development and growth of children. Study: Diminishing benefits of urban living for children and adolescents’ growth and development. Image Credit: Bricolage/Shutterstock Background The maturation and progress of children and adolescents in school are impacted by their nourishment and surroundings
0 Comments
Sugar-Free Peanut Butter Easter Eggs – Diabetes Daily Learning Center Learning Center: LearningCenter Diabetes Daily does not provide medical advice,diagnosis or treatment.Get additional information.© 2005 – 2023 Everyday Health, Inc., a Ziff Davis company. Everyday Health is among the federally registered trademarks of Everyday Health, Inc. and may not be used by third parties without
0 Comments
Members of the media ask questions to U.S. President Joe Biden as he walks to the Marine One helicopter to depart for travel to Mississippi to view tornado damage, from the White House in Washington, U.S., March 31, 2023.  Jonathan Ernst | Reuters The Biden administration on Friday appealed a Texas federal judge’s decision to
0 Comments
Sign up for CNN’s Wonder Theory science newsletter. Explore the universe with news on fascinating discoveries, scientific advancements and more. CNN  —  Astronaut Frank Rubio traveled to the International Space Station on September 21, 2022, for what he thought would be a six-month mission. But he’ll wind up staying in space for over a year
0 Comments
March 30, 2023 — Results from a multi-site clinical trial supported by the National Institutes of Health showed that less than 1% of people with opioid use disorder whose drug use includes fentanyl experienced withdrawal when starting buprenorphine in the emergency department. The findings, which appeared today in JAMA Network Open, are strong evidence that
0 Comments
Neural development is affected by early life adversity (ELA), which includes poverty and mistreatment or neglect by caregivers. One of the key mechanisms through which ELA inhibits optimal brain functioning is systemic low-grade inflammation. Moreover, ELA accelerates cellular senescence through DNA methylation of stress genes, which enhances the long-term risk for psychiatric and neurodegenerative disorders.
0 Comments
High-dose prophylactic anticoagulation or therapeutic anticoagulation reduced de novo thrombosis in patients with hypoxemic COVID-19 pneumonia, based on data from 334 adults. Patients with hypoxemic COVID-19 pneumonia are at increased risk of thrombosis and anticoagulation-related bleeding, therefore data to identify the lowest effective anticoagulant dose are needed, wrote Vincent Labbé, MD, of Sorbonne University, Paris, France, and
0 Comments
27 March 2023 — Positive high-level results from the NEURO-TTRansform Phase III trial in patients with hereditary transthyretin-mediated amyloid polyneuropathy (ATTRv-PN) showed eplontersen met its co-primary endpoints through 66 weeks. The results were consistent with the positive 35-week findings announced in June 2022.1 At 66 weeks, patients treated with eplontersen continued to demonstrate a statistically
0 Comments
In this article ILMN IEP Follow your favorite stocksCREATE FREE ACCOUNT Rafael Henrique | Lightrocket | Getty Images Illumina on Thursday urged shareholders to reject Carl Icahn’s three board nominees at this year’s annual meeting, saying they would “threaten the progress” of the biotech company’s core business.  “Carl Icahn’s involvement with Illumina risks the long-term
0 Comments